ArticleCureus2026
Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by diverse clinical manifestations. This case report describes a 14-year-old female patient diagnosed with neuropsychiatric SLE (NP-SLE) following status epilepticus. The patient was a 14-year-old previously healthy female and was transported to the emergency department owing to fever and status epilepticus. Based on imaging findings, clinical findings, and the patient's age, anti-N-methyl-D-aspartate (NMDA) receptor encephalitis (NMDARE) was suspected, and intensive care was initiated. However, persistent renal dysfunction and cytopenia prompted detailed investigation, leading to a diagnosis of NP-SLE. SLE is a systemic disease requiring long-term treatment. In such cases, where characteristic rashes are absent, differential diagnosis based on physical findings is difficult. Although NP-SLE and NMDARE share many standard features, including clinical symptoms and age of onset, measuring antinuclear antibody (ANA) and complement levels may be valuable in the differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.